The Role of ADCY1 in Regulating the Sensitivity of Platinum-Based Chemotherapy in NSCLC
Lung cancer has the highest fatality rate among malignant tumors in the world. Finding new biomarkers of drug resistance is of great importance in the prognosis of lung cancer patients. We found that the polymorphisms of Adenylate Cyclase 1 (ADCY1) are significantly associated with platinum-based ch...
Saved in:
Main Authors: | Ting Zou (Author), Jun-Yan Liu (Author), Zhao-Qian Liu (Author), Di Xiao (Author), Juan Chen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer
by: Chenxue Mao, et al.
Published: (2022) -
Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
by: Jia-Si Liu, et al.
Published: (2023) -
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
by: Ting Zou, et al.
Published: (2020) -
Genetic Variants in Double-Strand Break Repair Pathway Genes to Predict Platinum-Based Chemotherapy Prognosis in Patients With Lung Cancer
by: Jun-Yan Liu, et al.
Published: (2022) -
ADCY5 Mutations and Benign Hereditary Chorea
by: J. Gordon Millichap
Published: (2015)